Supplementation with milk fat globule membrane from early life reduces maternal separation-induced visceral pain independent of enteric nervous system or intestinal permeability changes in the rat.
Early life stress
Enteric nervous system
Maternal separation
Microbiota-gut-brain axis
Milk fat globule membrane
Visceral pain
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
received:
31
03
2021
revised:
23
01
2022
accepted:
06
03
2022
pubmed:
15
3
2022
medline:
8
4
2022
entrez:
14
3
2022
Statut:
ppublish
Résumé
Nutritional approaches have emerged over the past number of years as suitable interventions to ameliorate the enduring effects of early life stress. Maternal separation (MS) is a rodent model of early life stress which induces widespread changes across the microbiota-gut-brain axis. Milk fat globule membrane (MFGM) is a neuroactive membrane structure that surrounds milk fat globules in breast milk and has been shown to have positive health effects in infants, yet mechanisms behind this are not fully known. Here, we investigated the effects of MFGM supplementation from birth on a variety of gut-brain signalling pathways in MS and non-separated control animals across the lifespan. Specifically, visceral sensitivity as well as spatial and recognition memory were assessed in adulthood, while gut barrier permeability, enteric nervous system (ENS) and glial network structure were evaluated in both early life and adulthood. MS resulted in visceral hypersensitivity, which was ameliorated to a greater extent by supplementation with MFGM from birth. Modest effects of both MS and dietary supplementation were noted on spatial memory. No effects of MS were observed on enteric neuronal or glial networks in early life or adulthood, however an increase in the immunoreactivity of βIII-tubulin in adult colonic myenteric ganglia was noted in the MFGM intervention non-separated group. In conclusion, dietary supplementation with MFGM from birth is sufficient to block MS-induced visceral hypersensitivity, highlighting its potential value in visceral pain-associated disorders, but future studies are required to fully elucidate the mechanistic role of this supplementation on MS-induced visceral pain.
Identifiants
pubmed: 35283136
pii: S0028-3908(22)00085-5
doi: 10.1016/j.neuropharm.2022.109026
pii:
doi:
Substances chimiques
Glycolipids
0
Glycoproteins
0
milk fat globule
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109026Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.